Direxion Daily CSI China Internet Bull 2X Shares vs 22nd Century Group Inc — how do they compare? Direxion Daily CSI China Internet Bull 2X Shares trades at $18.24 (market cap $173.62M), while 22nd Century Group Inc trades at $0.89 (market cap $621.67K). The key difference: Direxion Daily CSI China Internet Bull 2X Shares is far larger — about 279.3× 22nd Century Group Inc's market cap, and Direxion Daily CSI China Internet Bull 2X Shares is more actively traded (551,726 versus 45,625). Which is the better fit depends on your goals — on Pluang, investors hold Direxion Daily CSI China Internet Bull 2X Shares for 24 Days and 22nd Century Group Inc for 32 Days on average.
| CWEB | XXII | |
|---|---|---|
Market Cap | $173.62M | $621.67K |
Volume | 551,726 | 45,625 |
Sector | Leveraged / Inverse | Consumer Staples |
52-Week High | $55.62 | $483.00 |
52-Week Low | $17.39 | $0.80 |
Typical Hold Time | 24 Days | 32 Days |
Enterprise Value | — | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
CWEB is trading at $18.02, down 1.85% on the day, with technical indicators showing a bearish trend across moving averages. The stock faces selling pressure with all 13 moving average signals bearish and key resistance levels clustered around $18. Recent news highlights China's AI ambitions and potential growth in China tech stocks as catalysts.
The outlook remains cautious due to technical weakness, though exposure to China's growing AI sector offers long-term potential. Key risks include China market volatility and competitive pressures. Investors should monitor earnings reports for fundamental validation of growth prospects.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
CWEB is a leveraged ETF that seeks to provide two times (2x) the daily performance of the CSI China Internet Index. It offers magnified exposure to top Chinese internet companies listed on US and Hong Kong exchanges.
Read more on CWEB →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →